The University of Texas- MD Anderson Cancer Center — Houston, Texas

The University of Texas- MD Anderson Cancer Center is a clinical research site located in Houston, Texas, United States.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

The University of Texas- MD Anderson Cancer Center has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, HER2 Positive Breast Cancer, Non-small Cell Lung Cancer.

Sponsors: Merrimack Pharmaceuticals, Teligene US, University of Pittsburgh.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Texas- MD Anderson Cancer Center?

The University of Texas- MD Anderson Cancer Center has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Texas- MD Anderson Cancer Center conducted?

The University of Texas- MD Anderson Cancer Center has 3 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, HER2 Positive Breast Cancer, Non-small Cell Lung Cancer.

Is The University of Texas- MD Anderson Cancer Center accredited by Crixeo Health?

The University of Texas- MD Anderson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Texas- MD Anderson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.